27 Internalization was measured by the loss of surface expression of the receptor (as HM781-36B in our study) and has also been seen in response to partial GLP-1R agonists.28 Although the confocal data are convincing and corroborate with our blots from the membrane and nuclear fractions, the immunoblot data regarding transfer of GLP-1R to the cytoplasmic fraction is not as robust as visualized in the confocal data. Future work to clarify the internalization results will need to be performed but are beyond the scope of the present study. New techniques may be feasible; for example, self-labeling protein

tags that are covalently linked with fluorophores and selectively label the specific pool of GPCRs present at the plasma membrane without labeling any of the internal pools. Thus, a nonpermeable labeled substrate will label only the plasma membrane–bound GPCR proteins. This selective labeling approach may significantly reduce the signal intensity obtained by the confocal microscopic examination of cells performed with exendin-4, as we have demonstrated

here. Although we have demonstrated the hepatic GLP-1 receptor can be internalized, the data cannot quantify the degree to which exendin-4 induces this process. Although we recognize that much of the work performed in this study was in transformed malignant hepatocyte Linsitinib in vivo cell lines (primarily Huh7 cells), the identification of GLP-1R was also performed in primary human hepatocytes. We suspect that one of the reasons that some (but not all) previous studies have not identified GLP-1R is the availability of better quality antibodies against MCE公司 the receptor and both the purity and availability of viable human hepatocytes for in vitro experimentation. These data are exciting

from a clinical and translational perspective, because they offer a plausible explanation as to why GLP-1 or GLP-like proteins may be beneficial in the treatment of the metabolic syndrome and NAFLD in particular. Importantly, these data indicate a direct effect of GLP-1 protein, as opposed to an indirect or pleotropic effect. As has been recently reported, patients undergoing bariatric surgery are found to have higher circulating levels of GLP-1 with significant histological improvement in their livers,29-32 especially those who undergo ileal transposition.31 In the present study, we provide evidence for direct cellular effects of GLP-1 proteins by potentiating hepatocyte steatosis in vitro by supplementing Huh7 cells with palmitic and oleic acids and gauging the reduction of steatosis by Oil Red O staining and supportive TG quantification. Flow cytometric analysis demonstrated that methionine-choline–deficiency increased cellular neutral lipid content, which was significantly decreased by exendin-4 treatment.